Cardiff Oncology, Inc. - Common Stock (CRDF)

Historical Holders from Q2 2020 to Q3 2025

Symbol
CRDF on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
66.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
25.2M
Holdings value
$51.8M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
109
Number of buys
48
Number of sells
-49
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cardiff Oncology, Inc. - Common Stock (CRDF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 5.8% +37.5% $10.7M $2.78M 3.84M +35.2% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 5.6% $11.7M 3.73M The Vanguard Group 30 Jun 2025
PFIZER INC 3.6% $6.7M 2.41M Pfizer Inc. 13-5315170 31 Dec 2024

Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 25.2M $51.8M -$9.7M $2.06 109
2025 Q2 28.7M $90.3M -$11.3M $3.15 114
2025 Q1 32.3M $102M +$10.2M $3.14 116
2024 Q4 28.1M $122M +$50.2M $4.34 117
2024 Q3 12.8M $34.1M -$896K $2.67 82
2024 Q2 13.1M $29.1M +$5.57M $2.22 90
2024 Q1 8.58M $45.8M +$17.9M $5.34 74
2023 Q4 5.31M $7.86M -$215K $1.48 55
2023 Q3 5.46M $7.58M -$757K $1.39 55
2023 Q2 5.99M $8.81M -$1.67M $1.47 50
2023 Q1 7.05M $11.6M -$749K $1.65 52
2022 Q4 7.7M $10.8M -$190K $1.40 55
2022 Q3 7.92M $12.2M -$1.96M $1.54 47
2022 Q2 8.93M $19.6M -$17.8M $2.20 54
2022 Q1 16.5M $41M -$30.2M $2.48 81
2021 Q4 22M $132M +$5.19M $6.01 81
2021 Q3 21.1M $141M -$36M $6.66 82
2021 Q2 26.5M $176M +$10.8M $6.65 81
2021 Q1 24.1M $223M -$69.8M $9.26 70
2020 Q4 26.6M $479M +$144M $17.99 79
2020 Q3 18.7M $266M +$208M $14.19 63
2020 Q2 4.92M $24.7M +$24.7M $5.01 23